Skip to main content
10 May 2025
Last updated:
Saturday 10 May 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
What Roche's takeover of Flatiron Health really means
Read more
Innate Pharma aims to regain leadership in IO
Read more
Antibody-degrading enzyme enables transplants
Read more
Mitochondrial quality control as potential therapy
Read more
Building a European capital market
Read more
The new complexity in clinical study protocols
Read more
Cell therapy success and the competition for value
Read more
Why pharma is paying a premium for assets
Read more
Takeovers refocus Sanofi on rare diseases
Read more
How GMO rules affect gene and cell therapies
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
34
Page
35
Page
36
Page
37
Current page
38
Page
39
Page
40
Page
41
Page
42
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
